Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Honokiol
Cat. No.:
OB0225LY-0486
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR, HPLC, and LC-MS.
Size:
Product Overview
Description:
Honokiol is the active ingredient of Magnolia extract that inhibits Akt activation and enhances ERK1/ERK2 phosphorylation.
Synonym:
NSC 293100; 35354-74-6; 5,3'-Diallyl-2,4'-dihydroxybiphenyl; 3,5'-Diallyl-4,2'-dihydroxybiphenyl; 3',5-Diallylbiphenyl-2,4'-diol
CAS No.:
35354-74-6
Compound CID:
72303
Formula:
C18H18O2
Formula Weight:
266.33
Specification
Relative Density:
1.107 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Honokiol can be used in cell biology research or play an important role in the study of neuroprotective and anti-tumor mechanisms.
Library Information
Targets:
Kinases; Viral enzymes
Receptors:
Akt; ERK1/ERK2; HCV Protease; MEK; P-Akt
Pathways:
Cytoskeletal signaling; Autophagy; MAPK; Microbiology/Virology; PI3K/Akt/mTOR signaling; Proteases/Proteasome
Plate Number:
AOCL-7
Plate Location:
c6
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
55 mg/mL; 206.51 mM
Ethanol Max Solubility:
26.6 mg/mL; 100 mM
ALogP:
4.88
HBA_Count:
0
HBD_Count:
2
Rotatable Bond:
5
